Investigating Minimal Residual Disease in Autopreserved Ovarian Tissue in Cases of Neoplastic Pathology

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Neoplastic PathologyAutopreserved Ovarian Tissue
Trial Locations (1)

25030

CHRU Besancon, Besançon

All Listed Sponsors
collaborator

CHU de Reims

OTHER

collaborator

University Hospital, Marseille

OTHER

collaborator

University Hospital, Lille

OTHER

collaborator

Central Hospital, Nancy, France

OTHER

collaborator

University Hospital, Grenoble

OTHER

collaborator

CMCO SIHCUS, Schiltingheim

OTHER

collaborator

University Hospital, Bordeaux

OTHER

collaborator

University Hospital, Limoges

OTHER

collaborator

Nantes University Hospital

OTHER

collaborator

University Hospital, Toulouse

OTHER

collaborator

University Hospital, Rouen

OTHER

lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02888145 - Investigating Minimal Residual Disease in Autopreserved Ovarian Tissue in Cases of Neoplastic Pathology | Biotech Hunter | Biotech Hunter